Erythropoietins should be used according to guidelines

Lancet Oncol. 2008 May;9(5):412-3. doi: 10.1016/S1470-2045(08)70115-3.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anemia / chemically induced
  • Anemia / drug therapy*
  • Antineoplastic Agents / adverse effects*
  • Drug Approval
  • Drug Labeling
  • Erythropoietin / adverse effects
  • Erythropoietin / analogs & derivatives
  • Erythropoietin / therapeutic use*
  • Guideline Adherence
  • Hematinics / adverse effects
  • Hematinics / therapeutic use*
  • Humans
  • Practice Guidelines as Topic
  • Risk Assessment
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Hematinics
  • Erythropoietin